How to Spot Market Leaders with the Relative Strength Line

“Top-performing stocks will lead the broader market averages at important turning points. As a bear market is bottoming, leading stocks, the ones that best resisted the decline, will turn up first and then sprint ahead – days, weeks, or even months before the Dow, S&P, and Nasdaq indexes put on their running shoes. These leadingContinue reading “How to Spot Market Leaders with the Relative Strength Line”

The green race: who will emerge victorious in the electric car revolution?

It is  no secret that in the last few years, as awareness of global climate change has been growing, the electric car industry has been thriving across financial markets, while petrol and diesel car stocks have been losing some of their appeal. This trend of green cars has been taking shape for quite some time.Continue reading “The green race: who will emerge victorious in the electric car revolution?”

Weekly Stock Market Update: US Markets Continue to Reach Record Highs

Last Week’s Top Five Market Winners Nasdaq Stock Market (NASDAQ) On the Nasdaq Stock Market, last week saw some positive results for Cellectis S.A. (CLLS), Ambarella Inc. (AMBA), Zscaler Inc. (ZS), Impinj Inc. (PI) and Moderna Inc. (MRNA). News that the US Food and Drug Administration (FDA) had lifted a hold placed on a PhaseContinue reading “Weekly Stock Market Update: US Markets Continue to Reach Record Highs”

Three rallying stocks to consider

Vaccine breakthroughs are like buses: the world waits for months for hopeful news, two then come along in quick succession. Markets rallied off the back of the announcements and lifted countless share prices in the process. Here, we delve into three such companies and assess the investment potential they can bring portfolios. Lloyds Banks wereContinue reading “Three rallying stocks to consider”

Second effective vaccine fuels rally, Tesla joins S&P

Dominating headlines yesterday was the news that Moderna’s Covid-19 vaccine has proven 94.5% effective in a late-stage trial, a week after Pfizer reported similar results in its own trial. More data is expected from the study later this month, and Moderna said that it plans to ask health authorities to clear the vaccine by earlyContinue reading “Second effective vaccine fuels rally, Tesla joins S&P”

Create your website with WordPress.com
Get started